Catalytic Properties of the Asparaginyl Hydroxylase (FIH) in the Oxygen Sensing Pathway Are Distinct from Those of Its Prolyl 4-Hydroxylases
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The activity of hypoxia-inducible transcription factor HIF, an alphabeta heterodimer that has an essential role in adaptation to low oxygen availability, is regulated by two oxygen-dependent hydroxylation events. Hydroxylation of specific proline residues by HIF prolyl 4-hydroxylases targets the HIF-alpha subunit for proteasomal destruction, whereas hydroxylation of an asparagine in the C-terminal transactivation domain prevents its interaction with the transcriptional coactivator p300. The HIF asparaginyl hydroxylase is identical to a previously known factor inhibiting HIF (FIH). We report here that recombinant FIH has unique catalytic and inhibitory properties when compared with those of the HIF prolyl 4-hydroxylases. FIH was found to require particularly long peptide substrates so that omission of only a few residues from the N or C terminus of a 35-residue HIF-1alpha sequence markedly reduced its substrate activity. Hydroxylation of two HIF-2alpha peptides was far less efficient than that of the corresponding HIF-1alpha peptides. The K(m) of FIH for O(2) was about 40% of its atmospheric concentration, being about one-third of those of the HIF prolyl 4-hydroxylases but 2.5 times that of the type I collagen prolyl 4-hydroxylase. Several 2-oxoglutarate analogs were found to inhibit FIH but with distinctly different potencies from the HIF prolyl 4-hydroxylases. For example, the two most potent HIF prolyl 4-hydroxylase inhibitors among the compounds studied were the least effective ones for FIH. It should therefore be possible to develop specific small molecule inhibitors for the two enzyme classes involved in the hypoxia response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FIH1 remains active at lower oxygen concentrations than the PHDs and so might suppress the activity of HIFα proteins that escape destruction in moderate hypoxia (Dayan et al., 2006; Koivunen et al., 2004).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Koivunen et al., 2004
In the citing paper
“Initially reported values for the apparent KM for oxygen (the concentration of oxygen that supports a half-maximal initial catalytic rate) were in the range of 230–250 μM for the PHDs and 90 μM for FIH1 (Hirsila et al., 2003; Koivunen et al., 2004).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Koivunen et al., 2004
In the citing paper
“both HIF hydroxylases belong to Fe2+-containing αKGDDs that require O2 and αKG as substrates. Because of their relatively lower affinity for O2 (Michaelis constant (Km) = 230–250 μM) compared with other αKGDDs76, under hypoxic conditions, PHDs and FIHs are inactive, leading to the stabilization and activation of HIF1.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [76]
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558
Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550
Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014
Semenza, G. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00518-9 · Cited by 935
HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation
Yu, F., White, S. B., Zhao, Q., & Lee, F. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181341498 · Cited by 796
Research works printed but not linked: 1
- Kivirikko, 1998, Adv. Enzymol. Relat. Areas Mol. Biol., 72, 325
Cited by
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
“FIH1 remains active at lower oxygen concentrations than the PHDs and so might suppress the activity of HIFa proteins that escape destruction in moderate hypoxia (Dayan et al., 2006; Koivunen et al., 2004).”
BackgroundOxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Hypoxia signalling in cancer and approaches to enforce tumour regression
Pouysségur, J., Dayan, F., & Mazure, N. M. (2006) · Nature · doi:10.1038/nature04871 · Cited by 1,676
“This model integrates the interesting finding that PHDs have a much lower affinity for oxygen and 2-oxoglutarate than FI”
BackgroundCellular Adaptation to Hypoxia through Hypoxia Inducible Factors and beyond
Lee, P., Chandel, N. S., & Simon, M. C. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0227-y · Cited by 1,272
Appelhoff, R. J., Tian, Y.-M., Raval, R. R., Turley, H., Harris, A. L., Pugh, C. W., Ratcliffe, P. J., & Gleadle, J. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406026200 · Cited by 1,108
The hypoxic tumour microenvironment
Petrova, V., Annicchiarico-Petruzzelli, M., Melino, G., & Amelio, I. (2018) · Oncogenesis · doi:10.1038/s41389-017-0011-9 · Cited by 1,019
Hydroxylation of HIF-1: Oxygen Sensing at the Molecular Level
Semenza, G. L. (2004) · Physiology · doi:10.1152/physiol.00001.2004 · Cited by 905
Transcriptional regulation by hypoxia inducible factors
Dengler, V. L., Galbraith, M. D., & Espinosa, J. M. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838205 · Cited by 782
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
Kaelin Jr, W. G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2502 · Cited by 726
“FIH1 has a lower O 2 K m than the Phd family member”
BackgroundTransformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Koivunen, P., Lee, S., Duncan, C. G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J. A., Joensuu, P., Bergmann, U., Gross, S., et al. (2012) · Nature · doi:10.1038/nature10898 · Cited by 727
“Human EGLN1, 2 and 3, collagen P4H-I and FIH, and murine Tet1 and Tet2 were produced in insect cells and purified as described earlie”
MethodSelf-citationHypoxia and Metabolic Adaptation of Cancer Cells
Eales, K. L., Hollinshead, K. E. R., & Tennant, D. A. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.50 · Cited by 724
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
Chiche, J., Brahimi‐Horn, M. C., & Pouysségur, J. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00994.x · Cited by 667
“), since the oxygen-dependent enzymes PHDs and FIH progressively become inactive [101].”
BackgroundPrabhakar, N. R., & Semenza, G. L. (2012) · Physiological Reviews · doi:10.1152/physrev.00030.2011 · Cited by 641
“FIH-1 has a Km for O2 (using HIF-1 peptides as substrates for in vitro hydroxylation) that is three times lower than the prolyl hydroxylases (161).”
Regulation of erythropoietin production
Jelkmann, W. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2010.195057 · Cited by 599
“According to in vitro assays, the K m values of the three PHDs for O2 are above the arterial PO2 (∼170 mmHg), whereas FIH-1 operates at a lower PO2 (∼60 mmHg) (Koivunen et al. 2004).”
BackgroundVascular endothelial growth factor (VEGF) signaling in tumor progression
Roskoski, R. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.01.006 · Cited by 599
Passing the baton: the HIF switch
Koh, M. Y., & Powis, G. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.06.004 · Cited by 589
“FIH-1 can also hydroxylate the corresponding Asn within HIF-2α, albeit at a much lower efficiency compared to HIF-1α [11].”
BackgroundInhibition of Hypoxia-inducible Factor (HIF) Hydroxylases by Citric Acid Cycle Intermediates
Koivunen, P., Hirsilä, M., Remes, A. M., Hassinen, I. E., Kivirikko, K. I., & Myllyharju, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610415200 · Cited by 521
Self-citationMetabolic zonation of the liver: The oxygen gradient revisited
Kietzmann, T. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.012 · Cited by 499
Regulation of angiogenesis by hypoxia-inducible factor 1
Hirota, K., & Semenza, G. L. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.12.003 · Cited by 464
Proline hydroxylation and gene expression
Kaelin, W. G. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133142 · Cited by 468
Targeting cancer vulnerabilities with high-dose vitamin C
Ngo, B., Van Riper, J. M., Cantley, L. C., & Yun, J. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0135-7 · Cited by 423
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
Schödel, J., Grampp, S., Maher, E. R., Moch, H., Ratcliffe, P. J., Russo, P., & Mole, D. R. (2016) · European Urology · doi:10.1016/j.eururo.2015.08.007 · Cited by 405
“Both HIF-1a and HIF-2a display different susceptibility to FIH1 and PHD-mediated prolyl hydroxylation.”
InfluentialNagao, A., Kobayashi, M., Koyasu, S., Chow, C. C. T., & Harada, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020238 · Cited by 402
The VHL/HIF axis in clear cell renal carcinoma
Shen, C., & Kaelin, W. G. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.06.001 · Cited by 388
Inhibition of 2-oxoglutarate dependent oxygenases
Rose, N. R., McDonough, M. A., King, O. N. F., Kawamura, A., & Schofield, C. J. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00203h · Cited by 390
Korbecki, J., Simińska, D., Gąssowska-Dobrowolska, M., Listos, J., Gutowska, I., Chlubek, D., & Baranowska-Bosiacka, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910701 · Cited by 380
Nox4: A Hydrogen Peroxide-Generating Oxygen Sensor
Nisimoto, Y., Diebold, B. A., Cosentino-Gomes, D., & Lambeth, J. D. (2014) · Biochemistry · doi:10.1021/bi500331y · Cited by 359
Human high-altitude adaptation: forward genetics meets the HIF pathway
Bigham, A. W., & Lee, F. S. (2014) · Genes & Development · doi:10.1101/gad.250167.114 · Cited by 349
“In general, both FIH and the PHDs more efficiently hydroxylate long peptide/protein substrates over short peptide substrates (Koivunen et al. 2004; Ehrismann et al. 2007).”
BackgroundKoh, M. Y., Lemos, R., Liu, X., & Powis, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4142 · Cited by 350
“On the other hand, prolonged or chronic hypoxia seems to favor activation of HIF-2a in most cell types, possibly because of differential affinities for specific regulators of stability and activity, such as the prolyl hydroxlases, factor inhibiting HIF, and also Hsp70, which promotes the ubiquitination and proteasomal…”
Signalling hypoxia by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.111 · Cited by 341
Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease
Fraisl, P., Aragonés, J., & Carmeliet, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2761 · Cited by 326
“These oxygen sensors have a relatively low affinity for oxygen, with K m values (100–250 μM for PHDs; 90 μM for FIH”
BackgroundLahiri, S., Roy, A., Baby, S. M., Hoshi, T., Semenza, G. L., & Prabhakar, N. R. (2006) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2005.07.001 · Cited by 312
Mechanisms of hypoxia signalling: new implications for nephrology
Schödel, J., & Ratcliffe, P. J. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0182-z · Cited by 309
Dayan, F., Roux, D., Brahimi-Horn, M. C., Pouyssegur, J., & Mazure, N. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4564 · Cited by 294
“Studies into the Km of the two oxygen sensors, PHD and FIH, indicate that the PHDs require higher oxygen levels than FIH for activity (16).”
BackgroundInfluentialSomatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
Minamishima, Y. A., Moslehi, J., Bardeesy, N., Cullen, D., Bronson, R. T., & Kaelin, W. G. (2008) · Blood · doi:10.1182/blood-2007-10-117812 · Cited by 294
Oxygen Sensors at the Crossroad of Metabolism
Aragonés, J., Fraisl, P., Baes, M., & Carmeliet, P. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.10.001 · Cited by 290
miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target
Serocki, M., Bartoszewska, S., Janaszak-Jasiecka, A., Ochocka, R. J., Collawn, J. F., & Bartoszewski, R. (2018) · Angiogenesis · doi:10.1007/s10456-018-9600-2 · Cited by 288
“In vitro studies show that the efficiency of hydroxylation of HIF-2α, by both the PHDs and FIH-1, is much lower than for HIF-1α, which results in the accumulation and activation of HIF-2α at higher oxygen tensions than HIF-1α [30].”
BackgroundKorbecki, J., Kojder, K., Kapczuk, P., Kupnicka, P., Gawrońska-Szklarz, B., Gutowska, I., Chlubek, D., & Baranowska-Bosiacka, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020843 · Cited by 273
“As FIH is an oxygen-dependent enzyme [35], its activity is reduced by chronic hypoxia and ROS which oxidize the iron atom—a part of the enzyme that is critical for its function [32].”
BackgroundHypoxia and Hypoxia-Inducible Factors in Kidney Injury and Repair
Shu, S., Wang, Y., Zheng, M., Liu, Z., Cai, J., Tang, C., & Dong, Z. (2019) · Cells · doi:10.3390/cells8030207 · Cited by 259
“Of note, FIH1 remains active at lower oxygen concentrations than PHDs, and may therefore inhibit the activity of HIF that has escaped PHD-mediated destruction during moderate hypoxia [34,35].”
BackgroundKaluz, S., Kaluzová, M., Liao, S.-Y., Lerman, M., & Stanbridge, E. J. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.01.001 · Cited by 248
“This led to the proposition that stabilization of HIF-1α precedes its transcriptional activation and that there might be a hypoxic window inwhich HIF-1α would be stable due to the absence of prolyl hydroxylation and yet would be transcriptionally inactive due to continued asparaginyl hydroxylation [60].”
The Asparaginyl Hydroxylase Factor Inhibiting HIF-1α Is an Essential Regulator of Metabolism
Zhang, N., Fu, Z., Linke, S., Chicher, J., Gorman, J. J., Visk, D., Haddad, G. G., Poellinger, L., Peet, D. J., Powell, F., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.001 · Cited by 246
“The FIH enzyme has a higher affinity for oxygen than the PHD enzymes (Koivunen et al., 2004; Peet et al., 2004).”
BackgroundTumor stroma: a complexity dictated by the hypoxic tumor microenvironment
Casazza, A., Di Conza, G., Wenes, M., Finisguerra, V, Deschoemaeker, S., & Mazzone, M. (2014) · Oncogene · doi:10.1038/onc.2013.121 · Cited by 243
Turn me on: regulating HIF transcriptional activity
Lisy, K., & Peet, D. J. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402315 · Cited by 233
Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression
Fandrey, J. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00577.2003 · Cited by 243
“Both PHDs and FIH-1 require O2.”
BackgroundInfluential2-Oxoglutarate-dependent dioxygenases in cancer
Losman, J.-A., Koivunen, P., & Kaelin, W. G. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-00303-3 · Cited by 230
Self-citationBrahimi-Horn, M. C., & Pouysségur, J. (2009) · Journal of Cell Science · doi:10.1242/jcs.035022 · Cited by 226
“These hydroxylation events are catalysed, respectively, by prolyl hydroxylase domain proteins (PHDs), of which there are three major isoforms (Schofield and Ratcliffe, 2004), and factor inhibiting HIF (FIH) (Peet and Linke, 2006).”
BackgroundInfluentialRegulating cellular oxygen sensing by hydroxylation
FANDREY, J., GORR, T., & GASSMANN, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.05.005 · Cited by 233
“For FIH-1, the Km was found to be considerably lower, 90 μM [40], but still more than twice as high as that of CP4H1 (40 μM; [41]).”
Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases
Hirota, K., & Semenza, G. L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.193 · Cited by 229
Regulatory mechanisms of hypoxia‐inducible factor 1 activity: Two decades of knowledge
Koyasu, S., Kobayashi, M., Goto, Y., Hiraoka, M., & Harada, H. (2018) · Cancer Science · doi:10.1111/cas.13483 · Cited by 225
“Although PHD and FIH-1 both function as sensors of oxygen concentrations and down-regulate the expression and transactivation activity of HIF-1a with their hydroxylation activities, their Km values differ from each other.(34,35) As the Km value of FIH-1 is markedly lower than that of PHD, the HIF-1a protein initially…”
BackgroundChang, S., Yim, S., & Park, H. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0230-6 · Cited by 228
King, O. N. F., Li, X. S., Sakurai, M., Kawamura, A., Rose, N. R., Ng, S. S., Quinn, A. M., Rai, G., Mott, B. T., Beswick, P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015535 · Cited by 223
“2,4-PDCA, a well-characterized 2OG analogue and inhibitor of many 2OG oxygenases [32,33,34,35], inhibits all the enzymes tested with IC50 values in the low micromolar range.”
BackgroundEhrismann, D., Flashman, E., Genn, D. N., Mathioudakis, N., Hewitson, K. S., Ratcliffe, P. J., & Schofield, C. J. (2007) · Biochemical Journal · doi:10.1042/bj20061151 · Cited by 225
Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway
Hirsilä, M., Koivunen, P., Xu, L., Seeley, T., Kivirikko, K. I., & Myllyharju, J. (2005) · The FASEB Journal · doi:10.1096/fj.04-3399fje · Cited by 221
“The specific activities of the recombinant HIF-P4Hs are about one-third and one-tenth of the highest values reported for purified recombinant human FIH (21) and type I C-P4H (32) but are very close to the highest values for the three isoenzymes of recombinant human lysyl hydroxylase (LH) (33), another 2oxoglutarate di…”
BackgroundMethodInfluentialSelf-citationSaxena, K., & Jolly, M. K. (2019) · Biomolecules · doi:10.3390/biom9080339 · Cited by 216
Bracken, C. P., Fedele, A. O., Linke, S., Balrak, W., Lisy, K., Whitelaw, M. L., & Peet, D. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600288200 · Cited by 222
Signalling via the hypoxia-inducible factor-1α requires multiple posttranslational modifications
Brahimi-Horn, C., Mazure, N., & Pouysségur, J. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.04.010 · Cited by 214
Ebbesen, P., Pettersen, E. O., Gorr, T. A., Jobst, G., Williams, K., Kieninger, J., Wenger, R. H., Pastorekova, S., Dubois, L., Lambin, P., et al. (2009) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360902784425 · Cited by 218
Pugliese, S. C., Poth, J. M., Fini, M. A., Olschewski, A., El Kasmi, K. C., & Stenmark, K. R. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00238.2014 · Cited by 214
The von Hippel–Lindau protein, HIF hydroxylation, and oxygen sensing
Kaelin, W. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.165 · Cited by 214
Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one?
Ozer, A., & Bruick, R. K. (2007) · Nature Chemical Biology · doi:10.1038/nchembio863 · Cited by 214
“In vitro , FIH-1 binds poorly to the HIF-α CTAD, with a K m ∼ 100 μM (ref”
Wilson, G. K., Tennant, D. A., & McKeating, J. A. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.025 · Cited by 204
“Although PHDs have a reported low affinity for oxygen (apparent Km in vitro of 230– 250 lM – a little over 21% O2), the Km of FIH is 90 lM ( 8%) [22,23].”
BackgroundTian, Y.-M., Yeoh, K. K., Lee, M. K., Eriksson, T., Kessler, B. M., Kramer, H. B., Edelmann, M. J., Willam, C., Pugh, C. W., Schofield, C. J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211110 · Cited by 182
Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence
Vissers, M. C. M., & Das, A. B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00809 · Cited by 188
“The HIF hydroxylases belong to the family of iron-containing dioxygenases that utilize oxygen and 2-oxoglutarate as substrates (Ozer and Bruick, 2007), and for which ascorbate functions as a co-factor, possibly by maintaining the active site Fe in the reduced state (Koivunen et al., 2004).”
Adaptive Responses to Hypoxia and/or Hyperoxia in Humans
Burtscher, J., Mallet, R. T., Pialoux, V., Millet, G. P., & Burtscher, M. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0280 · Cited by 196
“40% of normoxic O 2 concentrations (109), allows further HIF-a activation as hypoxia intensifies.”
Kaluz, S., Kaluzová, M., & Stanbridge, E. J. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.05.002 · Cited by 165
“Measurements of theKmof FIH-1 forO2 revealed that it is less thanhalf that of the PHD familymembers [49], suggesting that a hypoxicwindowcould exist in which HIF-1α would be stable due to the absence of prolyl hydroxylation and yet would be transcriptionally inactive due to hydroxylation of N803.”
BackgroundHIF in Kidney Disease and Development
Gunaratnam, L., & Bonventre, J. V. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070804 · Cited by 173
Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors
Chen, L., Endler, A., & Shibasaki, F. (2009) · Experimental and Molecular Medicine · doi:10.3858/emm.2009.41.12.103 · Cited by 164
“In addition to the protein degradation signaling, HIF-1α proteins are downregulated by an other oxygen-dependent inhibitor, factor inhibiting HIF-1 (FIH-1), which is an asparaginyl hydroxylase that hydroxylates an asparagine residue in the C-terminal transactivation domain (TAD), preventing the interaction of the prot…”
BackgroundSensing and responding to hypoxia via HIF in model invertebrates
Gorr, T. A., Gassmann, M., & Wappner, P. (2006) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2006.01.002 · Cited by 169
Hopkinson, R. J., Tumber, A., Yapp, C., Chowdhury, R., Aik, W., Che, K. H., Li, X. S., Kristensen, J. B. L., King, O. N. F., Chan, M. C., et al. (2013) · Chemical Science · doi:10.1039/c3sc51122g · Cited by 164
Haddad, J. J., & Harb, H. L. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.09.029 · Cited by 163
Kuiper, C., & Vissers, M. C. M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00359 · Cited by 163
“ASCORBATE AS REGULATOR OF 2-OGDD ACTIVITY The Km values for ascorbate for the HIF-hydroxylases and CP4H are relatively high [140–300 μM (33, 48, 49)], indicating high intracellular requirements and susceptibility to ascorbate loss.”
BackgroundStolze, I. P., Tian, Y.-M., Appelhoff, R. J., Turley, H., Wykoff, C. C., Gleadle, J. M., & Ratcliffe, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406713200 · Cited by 156
Cook, K. M., Hilton, S. T., Mecinović, J., Motherwell, W. B., Figg, W. D., & Schofield, C. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.009498 · Cited by 161
Epigenetic Regulation by Histone Demethylases in Hypoxia
Hancock, R. L., Dunne, K., Walport, L. J., Flashman, E., & Kawamura, A. (2015) · Epigenomics · doi:10.2217/epi.15.24 · Cited by 161
HIF-1: master and commander of the hypoxic world
Mazure, N. M., Brahimi-Horn, M. C., Berta, M., Benizri, E. I., Bilton, R. L., Dayan, F., Ginouvès, A., Berra, E., & Pouysségur, J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.022 · Cited by 181
Li, S. H., Shin, D. H., Chun, Y.-S., Lee, M. K., Kim, M.-S., & Park, J.-W. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0074 · Cited by 160
“Furthermore, the DMOG used in this study is known to inhibit FIH by competing with 2-oxoglutarate (27, 28).”
MethodHYPOXIA‐INDUCED ERYTHROPOIETIN PRODUCTION: A PARADIGM FOR OXYGEN‐REGULATED GENE EXPRESSION
Stockmann, C., & Fandrey, J. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04474.x · Cited by 153
“The significantly lower Km of FIH-1 suggests that a hypoxic window may exist in which HIF-1a would be stable owing to the absence of prolyl hydroxylation and yet be transcriptionally inactive owing to hydroxylation of Asn-803.”
BackgroundInfluentialRegulation of Hypoxia Inducible Factors (HIF) in Hypoxia and Normoxia During Placental Development
Patel, J., Landers, K., Mortimer, R. H., & Richard, K. (2010) · Placenta · doi:10.1016/j.placenta.2010.08.008 · Cited by 157
The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma
Luo, D., Wang, Z., Wu, J., Jiang, C., & Wu, J. (2014) · BioMed Research International · doi:10.1155/2014/409272 · Cited by 157
Luo, X., Liu, Y., Kubicek, S., Myllyharju, J., Tumber, A., Ng, S. S., Che, K. H., Podoll, J. D., Heightman, T. D., Oppermann, U. C. T., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja201597b · Cited by 165
Self-citationThe HIF pathway as a therapeutic target
Hewitson, K. S., & Schofield, C. J. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03202-7 · Cited by 163
Jaśkiewicz, M., Moszyńska, A., Króliczewski, J., Cabaj, A., Bartoszewska, S., Charzyńska, A., Gebert, M., Dąbrowski, M., Collawn, J. F., & Bartoszewski, R. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00408-7 · Cited by 143
“inhibiting HIF-1 (FIH-1) prevent HIF-1α accumulation and its related transcriptional activity [24, 54].”
BackgroundCytokines and the regulation of hypoxia-inducible factor (HIF)-1α
Haddad, J. J., & Harb, H. L. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.11.009 · Cited by 161
“Under non-hypoxic conditions, HIF-1a is hydroxylated by a prolyl hydroxylase enzyme [66–68].”
BackgroundToth, R. K., & Warfel, N. A. (2017) · Antioxidants · doi:10.3390/antiox6020027 · Cited by 147
“However, PHDs also require Fe(II) and 2-oxoglutarate as cofactors [115].”
BackgroundInfluentialKuiper, C., Molenaar, I. G. M., Dachs, G. U., Currie, M. J., Sykes, P. H., & Vissers, M. C. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0263 · Cited by 135
Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge
Carr, A. C., & Cook, J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01182 · Cited by 133
“In the early 2000s, vitamin C was demonstrated to regulate the transcription factor hypoxia inducible factor-1α (HIF1α) (Hirsila et al., 2003; Koivunen et al., 2004; Hirota and Semenza, 2005).”
BackgroundCarr, A. C., & Lykkesfeldt, J. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1744513 · Cited by 126
“…acts as a cofactor for the dioxygenase enzymes which hydroxylate specific proline and asparagine residues in HIF resulting in decreased DNA and coactivator binding and enhanced proteosomal degradation of the transcription factor (Hirsila et al. 2003; Koivunen et al. 2004; Hirota and Semenza 2005).”
BackgroundInfluentialHypoxic tumor microenvironment: Implications for cancer therapy
Roy, S., Kumaravel, S., Sharma, A., Duran, C. L., Bayless, K. J., & Chakraborty, S. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220934038 · Cited by 141
“These differences in stabilization patterns arise partly from the ease of hydroxylating HIF2⍺ by PHD and asparagynyl hydroxylases (FIH-1) during acutely low oxygen levels.(14) Multiple studies point to the temporal regulation of HIF1⍺ or HIF2⍺ levels during hypoxia.”
BackgroundKoivunen, P., Hirsilä, M., Kivirikko, K. I., & Myllyharju, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604628200 · Cited by 129
Self-citationRegulation of hypoxia‐inducible factor in kidney disease
Nangaku, M., Rosenberger, C., Heyman, S. N., & Eckardt, K. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12005 · Cited by 138
“This is reasonable because HIF-1 is a much more efficient substrate of FIH than HIF-2.(12)”
BackgroundInfluentialThe potential role of HIF on tumour progression and dissemination
Unwith, S., Zhao, H., Hennah, L., & Ma, D. (2014) · International Journal of Cancer · doi:10.1002/ijc.28889 · Cited by 134
Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
Chan, M. C., Holt‐Martyn, J. P., Schofield, C. J., & Ratcliffe, P. J. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.01.001 · Cited by 133
Hypoxia‐inducible factor 1: a new hope to counteract neurodegeneration?
Correia, S. C., & Moreira, P. I. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06443.x · Cited by 143
“blocking the recruitment of the co-activator p300/CBP (Hewitson et al. 2002; Lando et al. 2002; McNeill et al. 2002; Lee et al. 2003; Koivunen et al. 2004).”
Chemical and Functional Aspects of Posttranslational Modification of Proteins
Knorre, D. G., Kudryashova, N. V., & Godovikova, T. S. (2009) · Acta Naturae · doi:10.32607/actanaturae.10755 · Cited by 141
Siddiq, A., Aminova, L. R., & Ratan, R. R. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9268-7 · Cited by 129
“Pharmacological inhibition of these enzymes show that they can serve as a potential therapeutic target for the treatment of conditions that occur as a consequence of ischemia in a host of organs including the brain [27-34].”
BackgroundThe role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis
Muz, B., Khan, M. N., Kiriakidis, S., & Paleolog, E. M. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2568 · Cited by 131
“One property of FIH that contrasts with that of the PHD is its ability to function even in severe hypoxia [ 33 ].”
BackgroundDevelopment of novel therapeutic strategies that target HIF-1
Semenza, G. L. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.2.267 · Cited by 120
“As in the case of the prolyl hydroxylases, FIH-1 utilises O2 and α-ketoglutarate and contains Fe (II) in its active site, although it has a Km for O2 that is three times lower than the prolyl hydroxylases [34].”
BackgroundHarnessing the hypoxia-inducible factor in cancer and ischemic disease
Brahimi-Horn, M. C., & Pouysségur, J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.10.013 · Cited by 122
Kuiper, C., Dachs, G. U., Currie, M. J., & Vissers, M. C. M. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.01.033 · Cited by 117
“5 mM for PHD2 [38] and FIH [15], respectively), suggests tight binding.”
Metadata
- Authors
- Koivunen, P., Hirsilä, M., Günzler, V., Kivirikko, K. I., & Myllyharju, J.
- Affiliations
- University of Oulu (FI)
- FibroGen (United States) (US)
- Corresponding author
- Myllyharju, Johanna
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 279
- Issue
- 11
- Pages
- 9899-9904
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2048216460
- Cited by
- 447
- References
- 29
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 18 · 2023: 24 · 2022: 23 · 2021: 26 · 2020: 23 · 2019: 21 · 2018: 16 · 2017: 10 · 2016: 12 · 2015: 13 · 2014: 26 · 2013: 27 · 2012: 23
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6091 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- factor inhibiting HIF, asparaginyl hydroxylase, hypoxia-inducible factor, oxygen sensing, HIF-1α, HIF-2α, substrate specificity, oxygen affinity, enzyme inhibition, P300, hypoxia response, proteasomal degradation
- MeSH terms
- Animals, Hypoxia, Binding Sites, Catalysis, Cell Line, Dose-Response Relationship, Drug, Electrophoresis, Polyacrylamide Gel, Humans, Mixed Function Oxygenases, Insecta, Ketoglutaric Acids, Kinetics, Molecular Sequence Data, Nuclear Proteins, Oxygen, Peptides, Proline, Procollagen-Proline Dioxygenase, Protein Binding, Recombinant Proteins, Repressor Proteins, Time Factors, Transcription Factors, Trans-Activators, Protein Structure, Tertiary, Dimerization, Inhibitory Concentration 50, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.